Quantification of PI3K/AKT/mTOR pathway inhibition is predictive of biological response

被引：0
|
作者：
Van Brussel, A. [1 ]
Wesseling-Rozendaal, Y. [1 ]
Den Biezen, E. [1 ]
Neerken, S. [1 ]
van de Wiel, P. [1 ]
机构：
[1] InnoSIGN, Res & Dev, Eindhoven, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 211卷
关键词：
D O I：
10.1016/j.ejca.2024.114726
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PB196
引用
收藏
页码：S81 / S81
页数：1
相关论文
共 50 条
  • [21] Effect of inhibition of the PI3K/Akt/mTOR pathway on AR splicing and downstream targets
    Liu, XiaoMei
    Gomez-Pinillos, Alejandro
    Shah, Payal
    Lavilla, Carmencita
    Ferrari, Anna C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [22] Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway
    Morgan, Todd M.
    Koreckij, Theodore D.
    Corey, Eva
    CURRENT CANCER DRUG TARGETS, 2009, 9 (02) : 237 - 249
  • [23] Targeting the PI3K/Akt/mTOR Pathway in Ocular Neovascularization
    Sasore, Temitope
    Reynolds, Alison L.
    Kennedy, Breandan N.
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2014, 801 : 805 - 811
  • [24] Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma
    Westin, Jason R.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (05): : 335 - 342
  • [25] Evaluation of the PI3K/AKT/mTOR pathway in multiple sclerosis
    Mammana, Santa
    Fagone, Paolo
    Cavalli, Eugenio
    Basile, Maria Sofia
    Petralia, Maria Cristina
    Nicoletti, Ferdinando
    Mangano, Katia
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 : S51 - S51
  • [26] Targeting the PI3K/Akt/mTOR Pathway - Beyond Rapalogs
    Markman, Ben
    Dienstmann, Rodrigo
    Tabernero, Josep
    ONCOTARGET, 2010, 1 (07) : 530 - 543
  • [27] Stability Analysis of the PI3K–Akt–mTOR Signaling Pathway
    Sapega T.S.
    Guria G.T.
    Biophysics, 2020, 65 (2) : 259 - 267
  • [28] The pathway of PI3K/AKT/mTOR in pulmonary carcinoids.
    Zhang, Zixuan
    Wang, Mengzhao
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] The PI3K/Akt/mTOR Pathway as Therapeutic Target in Neuroblastoma
    Fulda, S.
    CURRENT CANCER DRUG TARGETS, 2009, 9 (06) : 729 - 737
  • [30] Targeting the mTOR/AKT/PI3K pathway in paediatric malignancies
    Pearson, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S74 - S74
12345